The novel treatment of the medication represents a significant development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide678209.win-blog.com/23334224/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment